Drawing for SMUVIGO

USPTO serial 79249558

SMUVIGO

Reviewed by CopyMark Law Group

Reg. 5760111Status 709
Filing date
Status date
Registration date
May 28, 2019
Examiner
DWYER, JOHN D
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SMUVIGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparationsSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 21, 2026CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 12, 2025C71TCANCELLED SECTION 71
Jul 4, 2025CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Aug 16, 2019GPNXNOTIFICATION PROCESSED BY IB
Jul 26, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 26, 2019FIMPFINAL DISPOSITION PROCESSED
Jun 27, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 28, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 20, 2019NPUBNOTICE OF PUBLICATION
Jan 25, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2019MAFRAPPLICATION FILING RECEIPT MAILED
Jan 19, 2019DOCKASSIGNED TO EXAMINER
Jan 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 10, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance